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Expression of the Cytoplasmic Tail of LMP1 in Mice
Induces Hyperactivation of B Lymphocytes
and Disordered Lymphoid Architecture
1984), encoded by the viral genome, is essential for EBV-
mediated transformation of fibroblasts and primary B
cells (Kaye et al., 1993; Wang et al., 1985) and sufficient
for transformation of rodent fibroblasts (Wang et al.,
1985). It is expressed by virtually all EBV-associated
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LMP1 in epithelial cells via TRADD (Izumi and Kieff,
1997), but in B cells expressing endogenous TRADD
and TRAF6 we fail to see any direct association withSummary
either WT LMP1 or CD40-LMP1 molecules (Busch and
Bishop, 2001), (P. Xie and G.A.B., unpublished data).The oncogenic EBV protein LMP1 mimics a dysregu-
Others fail to see these interactions in lymphoblastoidlated CD40 receptor in vitro. To compare CD40 and
or nasopharyngeal carcinoma cells (Ardila-Osorio et al.,LMP1-mediated events in vivo, transgenic mice were
1999). Studies with TRAF6/ mouse embryonic fibro-engineered to express mouse CD40 (mCD40tg) or a
blasts are consistent with an indirect role for TRAF6 inprotein with extracellular mCD40 and cytoplasmic
LMP1 signaling (Schultheiss et al., 2001; Wan et al.,LMP1 (mCD40-LMP1tg). Transgenic and CD40/mice
2004).were bred so that only the transgenic CD40 molecule
Downstream LMP1-activated events overlap withis expressed in B cells, macrophages, and dendritic
those induced by CD40 (Busch and Bishop, 1999; Huencells. mCD40-LMP1tg mice had normal lymphocyte
et al., 1995; Kilger et al., 1998; Uchida et al., 1999). Full-subsets, and immunization elicited an antibody re-
length wild-type (WT) LMP1 has 6 transmembrane (TM)sponse featuring normal isotype switching, affinity
domains that self-aggregate (Liebowitz et al., 1986), andmaturation, and germinal center (GC) formation. How-
a portion of LMP1 molecules are constitutively localizedever, unimmunized mCD40-LMP1tg mice had expanded
to membrane rafts associated with TRAFs (Brown et al.,immature and germinal center B cells, produced autoan-
2001). We have developed a system to study LMP1tibodies, exhibited marked splenomegaly and lymph-
signaling that utilizes a chimeric molecule with the extra-adenopathy, and elevated serum IL-6. Thus, signaling
cellular (EC) and TM portions of CD40 and the cyto-
through the LMP1 cytoplasmic tail results in amplified
plasmic carboxyl terminal (CY) tail of LMP1 (Brown et
and abnormal mimicry of CD40 functions in vivo, indi-
al., 2001; Busch and Bishop, 2001). Unlike WT LMP1,
cating possible ways in which LMP1 contributes to the this molecule is not constitutively active but can be
pathogenesis of EBV-associated human disease. activated when crosslinked by anti-CD40 Abs or CD154.
The chimeric molecule and inducible wt LMP1 signal
Introduction similarly in B cells (Busch and Bishop, 1999, 2001; Brown
et al. 2001).
CD40 is a signaling molecule expressed on antigen- Our goal in producing a transgenic mouse signaling
presenting cells that is critically important in T cell-B through LMP1 was to determine the biological effects
cell interactions required for the development of a com- of signaling via the two different CY domains in the intact
plete T dependent (TD) antibody (Ab) response (Bishop animal. Natural EBV latency is believed to be established
and Hostager, 2001; Foy et al., 1993, 1994, 1996). When in antigen-experienced mature B cells, so rather than
engaged by CD154, CD40 moves to membrane rafts expressing the wt self-aggregating LMP1 molecule,
and recruits TRAF adaptor proteins (Hostager et al., which would begin to signal as soon as it was expressed,
2000), resulting in the triggering of signaling cascades. we designed our system to permit greater control over
These stimulate B cell effector functions, including upregu- signal initiation. We produced mice bearing transgenes
lation of surface receptors, cytokine and Ig secretion, encoding either full-length mouse CD40 (mCD40) or a
isotype switching, and development of B cell memory chimeric molecule with the EC and TM domains of
(Bishop and Hostager, 2001). mCD40, and the CY tail of LMP1 (mCD40-LMP1). Be-
cause the tg molecules could be engaged by endoge-The human herpes virus Epstein-Barr virus (EBV) is
nous CD154, the consequences of signaling throughB lymphotropic. The multimembrane spanning protein
CD40 or LMP1 CY tails could be directly compared.latent membrane protein 1 (LMP1) (Fennewald et al.,
These tg mice have been crossed onto CD40/ mice
(Kawabe et al., 1994), so the only functional CD40 EC*Correspondence: gail-bishop@uiowa.edu
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press CD40, including B cells, macrophages, and bone mately twice the level of CD40 expressed on C57Bl/6 B
cells (data not shown).marrow-derived dendritic cells (BM-DC). mCD40-LMP1tg,
but not mCD40tg mice, exhibited a phenotype of en-
largement of the SP and LNs and disordered splenic Lymphoid Compartment Characterization
organization. Either the mCD40-LMP1tg or the control LN and SP were examined for the distribution of B220
mCD40tg restored to CD40/ mice the ability to mount and CD3 cells. Total number of lymphocytes recov-
an antigen-specific IgG1 response with affinity matura- ered/mCD40-LMP1tg SP was similar to mCD40tg or
tion and the ability to form GC. mCD40-LMP1 mice have C57Bl/6 SP. B cell percentage was similar for the
elevated serum levels of anti-dsDNA Abs, anti-phospho- mCD40-LMP1tg, mCD40tg and C57Bl/6 mice, but T cells
lipid Ab, and IL-6. Overall, this phenotype indicates that were decreased 10% in mCD40-LMP1 SP (Figure 3A).
LMP1 signals, in contrast to CD40 signals, predispose A variable 2-fold increase in percentage of CD11b
B cells to hyperactivation in vivo, which may contribute cells was seen in mCD40-LMP1tg SP (S1). LNs from
to the development of autoreactivity and abnormal cell mCD40-LMP1tg mice showed a relative expansion of
accumulation or survival. B220 cells, with a compensatory decrease in CD3
cells compared to mCD40tg or C57Bl/6 LNs (Figure 3A).
However, the total number of lymphocytes recoveredResults
from mCD40-LMP1tg LNs was dramatically increased.
The percentage of CD11b and CD11c LN cells wasTg Mice
similar in C57Bl/6 and mCD40-LMP1 mice (S1).Sequences encoding full-length mCD40 or mCD40-
Detailed analysis of the lymphoid compartments ofLMP1 were inserted into the plasmid pBlDOI (Figure 1A)
the tg mice was performed to determine whetherunder control of the MHC class II E promoter because
lymphoid development is normal (Figures 3B and 3C).the expression patterns of CD40 and MHC class II largely
Follicular (FO), marginal zone (MZ), and immature B cellsoverlap. Further details are in the Experimental Proce-
were all present in mCD40-LMP1 and mCD40tg micedures. Mice produced were bred to C57Bl/6 mice. Prog-
(Figure 3B) (Hardy and Hayakawa, 2001). Of interest,eny were screened for transgenes by Southern blot (data
the immature SP B cell compartment was expanded innot shown) and PCR analysis of genomic DNA by using
mCD40-LMP1 mice, with approximately twice as manytg-specific primers (Figure 1B). Splenocytes from tg
B220 splenocytes in the CD21/35lowCD23lowB220mice produced specific RNA detected by RNase protec-
compartment as in mCD40tg or C57Bl/6 mice (Figuretion assay (RPA) (Figure 1C). mCD40-LMP1tg mice pro-
3B). Strikingly, mCD40-LMP1 mice, but not controls,duced a protein of 75–80 kDa reactive with anti-LMP1
showed evidence of GC B cells (Figure 3B, confirmed byAb (Figure 1D). Three mCD40-LMP1tg and 4 mCD40tg
immunohistochemistry, data not shown). B220PNAfounders were bred to CD40/ mice on a C57Bl/6 NCR
cells in SPs from unimmunized mCD40-LMP1tg micebackground (Kawabe et al., 1994). Offspring were screened
were 5.4% of total lymphocytes  0.2%, n  5, whileby PCR using primers specific for the transgene, the
in C57Bl/6 mice the proportion of these cells was 1.9%endogenous mCD40 gene, or the neoR-coding CD40KO
0.5%, n  3, and mCD40tg 2.4%  1.2%, n  3. BM ofgene insert in CD40/ mice (Figure 1B). In each genera-
both mCD40-LMP1tg and mCD40tg mice showed alltion, the tg, endogenous CD40-negative mice were
expected B cell populations, though in the mCD40-bred to CD40/ mice. Tg mice presented in Figures 3–7
LMP1tg BM the IgMB220 immature B cell populationhave all been backcrossed onto the CD40/ C57Bl/6
was reduced (Figure 3C). Cells isolated from the perito-background for five to eight generations. mCD40tg mice
neal cavity showed both B1 and B2 B cells in all groups,served as a control both for the promoter used to drive
in similar proportions (Figure 3C). The splenic T cellexpression of both the transgenes and for residual SJL-
compartment of the mCD40-LMP1tg and mCD40tgderived genes contributed by the injected oocytes, as
showed normal distribution of CD4 and CD8 cells, andthey have been backcrossed for the same number of
thymic subsets appeared normal (data not shown).generations to the CD40/ C57Bl/6 mice.
Serum IgTg Expression
We wished to determine if the presence of either tgOur goal was to directly compare in vivo outcomes of
would reconstitute the ability of B cells to undergo iso-signaling by the CY domains of CD40 versus LMP1, so
type switching, an event that is defective in CD40/it was important to express both tg molecules on the
mice (Kawabe et al., 1994). Both mCD40tg and mCD40-hematopoietic cells that normally express CD40: B lym-
LMP1tg mice had serum IgG1, IgG2b, IgA, and IgE similarphocytes, macrophages, and DC. B cells from two
to C57Bl/6 mice (S2), while CD40/ mice had low levelsmCD40tg lines and a mCD40-LMP1tg line expressed
of switched isotypes and elevated IgM (S2). IgM levelssurface tg protein at similar levels as detected by anti-
were 2- to 3-fold higher in mCD40-LMP1 and mCD40tgmCD40 mAbs (Figure 2A and data not shown), while
sera than in C57Bl/6 mice. We conclude that either theBM macrophages showed some variability in transgene
mCD40tg-encoded protein or the mCD40-LMP1 chime-expression (Figure 2B). The CD11bCD40 population
ric protein can induce isotype switching.seen clearly in the mCD40-LMP1tg and CD40/ plots
is neutrophils. A population of BM-DC (CD11c) ex-
pressed tg protein in each of the three lines shown in Antigen-Dependent Humoral Responses
Response to TD AntigenFigure 2C. We selected one mCD40-LMP1tg and two
CD40tg lines for further study for comparable levels of CD40 signals are of particular importance in humoral
responses to TD antigens (Kawabe et al., 1994). Thus,expression of the tg proteins on their B cells, approxi-
In Vivo Responses to LMP1 versus CD40
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Figure 1. Production of Transgenic Mice
(A) mCD40-LMP1 construct. The tg was excised with SacII and ClaI before microinjection into fertilized mouse eggs. Asterisks indicate binding
sites for PCR screening primers. The mCD40tg construct has the same extracellular and transmembrane sequence as the mCD40-LMP1 tg
without substitution of the LMP1 CY tail.
(B) Genomic DNA analysis. Three sets of PCR primers (T, K, and E) were used to characterize offspring of matings of mCD40-LMP1tg or
mCD40tg founders with CD40/ mice. One primer pair detects either tg because it is specific for DNA encoding the extracellular portion of
the molecule (T, 482 bp), another detects the endogenous mCD40 gene (E, 785bp), and a third (K, 882 bp) detects the CD40 KO gene with
neo insert (Kawabe et al., 1994). Primers for endogenous CD40 also detect the larger CD40 KO gene (2000 bp). The bolded “M” designates
lanes with molecular size markers. Tg-negative littermates (last set of three lanes) were used as CD40/ mice in experiments.
(C) Tg expression. RNA was purified from SPs of two offspring from the breeding of three different mCD40-LMP1 founders (L1, L2, L3) to
C57Bl/6 mice. Presence or absence of the tg in genomic DNA as detected by PCR is indicated by  or . The mCD40-LMP1 RNA is visible
as a protected band running at higher MW than the protected endogenous mCD40 band. L32 is a loading control. Lane 1 shows the presence
of only endogenous mCD40 RNA; all other mice tested show the presence of both tg-encoded and endogenous RNA. The founder represented
by L3 was used to breed the line of mCD40-LMP1 mice examined here.
(D) Tg protein expression. Western blots were prepared from lysates of SPs of two tg mCD40-LMP1tg mice and a tg- littermate from the
same line. The presence of the tg by PCR is indicated by  or . The mCD40-LMP1 chimeric protein is detected by S12 anti-LMP1 as a
75–80 kDa band. Reactivity of the secondary Ab with the Ig light chain band in the lower panel shows equal lane loading.
mCD40-LMP1tg, mCD40tg, CD40/, and C57Bl/6 mice 14 TNP-specific IgG1 Abs for all groups except CD40/
mice showed minimal maturation of Ab affinity (Figurewere immunized with TNP-KLH. Sera were obtained
prior to immunization and on days 7, 14, and 28 postim- 4C), as published (Takahashi et al., 1998). TNP-specific
Abs in day 28 sera showed a marked increase in affinitymunization, with a boost on day 21. Preimmune levels
of IgG1 and IgM anti-TNP were below the level of detec- compared to day 14 sera, with no significant difference
between the average affinity maturation ratios for C57Bl/6,tion to very low in sera from all groups, (data not shown).
All mice developed an Ag-specific IgM response (Fig- mCD40-LMP1tg mice, and the two mCD40tg lines.
Therefore, both the mCD40tg and the mCD40-LMP1tgures 4A and 4B), and all but the CD40/ mice developed
an IgG1 antigen-specific response by day 28. Though restored the ability of CD40/ mice to carry out Ig affin-
ity maturation. It has been reported that B cells fromthe average total IgG1 anti-TNP response appeared
higher in the C57Bl/6 mice, differences were not statisti- mice tg for wt LMP1 expressed only in B cells do not
show Ig affinity maturation in response to immunizationcally significant. We conclude that signaling through
either CD40 or LMP1 CY domains is sufficient to restore (Uchida et al., 1999). This could be due to unique quali-
ties of the wt LMP1 molecule, which signals constitu-a normal TD response.
Ab Affinity Maturation tively from early in development in those mice, or could
reflect the absence of CD40 on DC and/or macrophages.An important feature of humoral memory to which CD40
contributes is development of Ig affinity maturation. Day In contrast, our data demonstrate that the CY domain
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Figure 2. Tg Expression in B Cells, Macrophages, and DC
(A) Splenocytes from two lines of CD40/ mCD40tg mice (CD40tgA and CD40tgB) and one mCD40-LMP1tg line were stained for the mCD40
extracellular domain by using anti-mCD40-FITC and anti-B220-Cy5 to stain B cells. A mouse with one allele of endogenous mCD40 and one
of KO CD40 (CD40/) was included for comparison. The two mCD40tg lines were tested in the same experiment and the mCD40-LMP1tg
and CD40/ mice were tested separately. Populations were scatter gated to include lymphocytes.
(B) B220 BM cells from the same mice examined in (A) were stained with anti-CD40 and anti-CD11b to determine macrophage expression
of the tg; these cells were not scatter gated.
(C) DC were derived from the BM of mCD40-LMP1 and mCD40tgA and mCD40tgB mice as described in the Experimental Procedures. Ungated
cells were stained with anti-CD11c and anti-CD40. Lines indicate staining levels of isotype controls, and numbers identify the percentage of
cells in each quadrant.
of LMP1 can support a TD response when expressed had increased numbers of brightly staining IgM (Figure
5B) and IgG (data not shown) plasma cells throughoutin all hematopoietic cells normally expressing CD40.
GC Formation the red pulp. Thus signaling through the CY tail of LMP1
can substitute for CD40 in the GC response. However,CD40/ mice show a dramatic failure to form GC when
challenged with TD Ag (Kawabe et al., 1994). To further our results suggest that the CD40 CY domain may con-
tain unique features that stimulate optimal organizationexplore the TD response of mCD40-LMP1tg mice, we
examined the GC reaction. Frozen SP sections from of cells within GC.
mice immunized 11 days prior with 10% SRBC were
examined for the presence of GC (Figures 5A–5D). Clus- LN and SP Weights
The SPs of mCD40-LMP1tg mice were 2.5 times theters of PNA cells were observed in follicles of C57Bl/6
(Figure 5A), mCD40-LMP1tg (Figure 5B), and mCD40tg size of those of C57Bl/6 mice, mCD40tg mice, and
CD40/ mice (Figure 6A), a difference seen by 8–10SPs (Figure 5C) at the interface of B and T cell zones. The
mCD40tg had GC formation similar to C57Bl/6 controls weeks. Over 8 weeks to 12 months, there was no pro-
gressive increase in SP size. Of particular interest, in-(Figures 5A and 5C), while CD40/ mice failed to form
splenic GC (Figure 5D) as reported (Kawabe et al., 1994). crease in SP size did not appear due to accumulation
of lymphocytes, as the lymphocyte yield/gram SP wasThe PNA B cells in SP of mCD40-LMP1tg mice repre-
sented a greater proportion of B220 cells in immunized 2- to 3-fold lower for mCD40-LMP1tg mice compared
to SPs of controls (2.1  0.6  108/g LMP1 SP, 5.6 mCD40-LMP1 mice compared to controls and were ap-
proximately twice the number seen in naive mCD40- 2.3  108/g C57Bl/6 SP, 6.5  2.1  108/g mCD40tg SP,
5.0  2.3  108/g CD40/ SP). Also, the white pulp ofLMP1 mice. Examination of the SP sections revealed
that while mCD40-LMP1tg mice could generate GC, the mCD40-LMP1 SPs was reduced (Figure 5).
LN size of mCD40-LMP1tg mice was even more mark-their follicles were smaller than those in controls, and
In Vivo Responses to LMP1 versus CD40
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Figure 3. Analysis of Lymphocyte Subpopulations
(A) T cells are reduced in LMP1tg LN and SP, and B cells are expanded in LN, but not SP. SP and LN cells were stained with anti-B220 Cy5
and anti-CD3 PE, and analyzed by flow cytometry. Data presented are means  SEM of three to five mice per group tested in independent
experiments. The mCD40-LMP1tg SPs have a significant reduction in CD3 cells compared to other groups (p  0.03), but there is no
significant difference in the percentage of B220 cells in the three groups. The relative increase in B220 cells and decrease in CD3 cells
in the mCD40-LMP1 LN is significantly different from both mCD40tg and C57Bl/6 mice (p  0.05).
(B and C) Lymphoid compartments. (B) Splenocytes isolated from C57Bl/6 (top), mCD40-LMP1tg (middle), and mCD40tg mice (bottom) were
stained with Abs to the indicated markers to identify B cell subsets. Abbreviations: MZ, marginal zone B cells; IMM, immature; and FO,
follicular B cells. (C) BM cells and cells obtained by peritoneal lavage were stained with Abs to the indicated markers. The pre-B, IgM B,
and B1 and B2 subsets are indicated. 3mice from each group have been examined.
edly increased than SP size (Figure 6A). In LN, however, Bishop, 1999), a response that appears to be dependent
upon TRAF6 (Baccam et al., 2003; Jalukar et al., 2000).the increased size was accompanied by a large increase
in lymphocytes. The average weight of cervical nodes mCD40-LMP1tg mice showed significantly elevated lev-
els of serum IL-6 when compared to other mice testedfrom LMP1tg mice was 	9 times that of other groups
(Figure 6A). Total lymphocytes recovered from all LNs (Figure 6B). When stimulated in vitro, T depleted spleno-
cytes of mCD40-LMP1tg mice produced IL-6 in re-of mCD40-LMP1tg mice were 5–33 times the number
recovered from C57Bl/6 or mCD40tg mice, reflecting sponse to anti-CD40 Ab, while cells from any of the
other mice tested required a membrane CD154 stimulusaccumulation of B cells and to a lesser degree T cells
(Figure 3A). In addition, mCD40-LMP1tg mice from two (Figure 6C). The majority of the IL-6 in anti-CD40 Ab-
stimulated splenocyte cultures appears to be producedother founders were examined and in both cases SPs
and LNs were enlarged, suggesting that this is a property by macrophages, with a smaller contribution by B cells
(S3, S4). This suggests that the CY tail of LMP1 providesconferred by the transgene and not a founder effect.
Thus LMP1 can stimulate aberrant cell growth, accumu- a more potent signal than the CD40 CY tail in the induc-
tion of IL-6.lation, and/or survival, consistent with the tumorigenic
properties of EBV in humans.
Autoimmunity
mCD40-LMP1tg mice show evidence of chronic lympho-IL-6
IL-6 enhances B cell viability, and its overproduction is cyte activation, including splenomegaly, lymphadenop-
athy, elevated serum IL-6, and spontaneous GCs. EBVseen in human B cell lymphomas (reviewed in (Kurzrock,
2001). B cells produce IL-6 in response to membrane infection has been associated with increased suscepti-
bility to autoimmune diseases, including systemic lupusbound CD154, but not anti-CD40 Ab (Baccam and
Immunity
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Figure 4. Ag-Specific Responses
(A) Mice immunized with 100 
g TNP-KLH i.p. and boosted on day 21 were bled on day 28, and their Ag-specific serum IgM and IgG1 responses
were evaluated by ELISA. The data are means  SEM of four to ten mice/group. Data represent three similar assays.
(B) Affinity maturation of the day 14 and day 28 TNP-specific serum IgG1 response was assessed as in the Experimental Procedures. The
ratio of Ab binding to low-density hapten (TNP3-BSA) versus high-density hapten (TNP28-BSA) is plotted for mean values for four to ten mice/
group  SEM. The affinity ratio of MOPC 21 in these assays was 0.03. Results are representative of three similar assays.
erythematosus (SLE) and rheumatoid arthritis (RA) signs of autoimmune reactivity. Sera (14/29) from 2- to
8-month-old mice tested positive for the presence of(James and Harley, 1998; Rhodus, 1999). We hypothe-
sized that the mCD40-LMP1tg mice might also show anti-ds DNA Abs (Figure 7A), while positive sera were
Figure 5. Splenic Architecture
Frozen, fixed sections were prepared from
SP of mice 11 days after SRBC immunization.
Sections were stained with fluorescent anti-
CD3-PE (red), PNA-biotin  avidin-Alexa
Fluor 350 (blue), and anti-IgM-FITC (green).
(A) C57Bl/6, (B) mCD40-LMP1tg, (C) mCD40tgB,
and (D) CD40/.
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Figure 6. SP and LN Weights, Serum IL-6, and In Vitro IL-6 Production
(A) Weights of SP and LN in grams of each of the lines tested. Data are means SEM of 7–15 mice/group for SP. mCD40-LMP1tg is significantly
higher than other groups (p  0.01). LN weights are the total of four cervical nodes/mouse, four to five mice/group  SEM, and mCD40-
LMP1tg is significantly higher than other groups (p  0.01).
(B) Serum IL-6. Sera from 2- to 8-month-old unimmunized mice were tested for IL-6 by ELISA. Each point represents one mouse, and means
are indicated by horizontal bars. The lower level of detection was 4 pg/ml. Serum IL-6 levels were significantly higher in mCD40-LMP1 mice
than C57Bl/6 (p  0.05).
(C) T depleted splenocytes from four lines (mCD40-LMP1tg, mCD40tgB, CD40/, and C57Bl/6) were cultured with the indicated stimuli, as
described in the Experimental Procedures. Supernatants were analyzed for IL-6 by ELISA. Data are mean ng IL-6/ml  1 SEM for triplicate
cultures. The lower limit of sensitivity was 0.7 ng/ml. Results are representative of 	6 experiments.
much less common in the other groups. In addition, (Figure 7B). Preliminary experiments in the B cell-depen-
dent, collagen-induced arthritis model developed in12/16 mCD40-LMP1tg mice tested had anti-phospho-
lipid Ab, compared to 0/21 of mice in the other groups C57Bl/6 mice (Campbell et al., 2000) show that mCD40-
Figure 7. Spontaneous Autoimmunity
(A) Sera from 2- to 8-month-old unimmunized mice were screened at a 1:100 dilution for anti-dsDNA Abs. Results are compiled from four
experiments, with numbers of mice tested: mCD40-LMP1, 29; mCD40tg, 17; CD40/, 13; and C57Bl/6, 19. The mCD40-LMP1tg mice are
significantly more likely to have anti-dsDNA Ab than the other mice (p  0.0002).
(B) Anti-phospholipid Ab were tested in serum from 2- to 8-month-old unimmunized mice by ELISA. Data are means of duplicate wells; all
values shown are sera tested together in one assay. The OD of the negative control serum  3 SD defined positive and negative tests. Positive
control serum gave an OD of 1.27. mCD40-LMP1tg mice were significantly more likely to test positive for anti-phospholipid Ab than other
mice (p  0.0001).
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LMP1tg mice have sustained and elevated disease shared with CD40, or engagement of additional path-
ways. The mCD40-LMP1tg cells respond to CD40 Absymptoms (M.E.M. and G.A.B., unpublished data).
ex vivo by producing IL-6, and the mice have elevated
serum IL-6, suggesting that engagement of mCD40-Discussion
LMP1 cells by endogenous CD154 in vivo is sufficient
to stimulate production of IL-6.Our goal was to directly compare the biologic effects
LMP1 expression is associated with IL-6 secretionon the mature B cell response of signaling through CD40
(Busch and Bishop, 1999; Eliopoulos et al., 1997), andversus its viral mimic LMP1. We developed two types
elevated IL-6 levels are consistent with the phenotypeof tg mice in which signaling is initiated in the same
of mCD40-LMP1tg mice. Splenomegaly, lymphadenop-way through each tg receptor, so differences can be
athy, and plasmacytosis have been reported in miceattributed to CY domain differences. We find that the
overexpressing IL-6 (Ishihara and Hirano, 2002) and inLMP1 CY tail is an excellent mimic of the CD40 CY tail
humans with Castleman’s disease, which can be amelio-when expressed in vivo in B cells, macrophages, and
rated by treatment with Ab to IL-6 receptor (NishimotoDC, supporting normal lymphoid development, and de-
et al., 2000). In addition, IL-6 bioactivity is elevated invelopment of a TD response with isotype switching, GC
serum of MRL lpr/lpr mice (Tang et al., 1991), and treat-formation, and affinity maturation. However, mCD40-
ment with Ab to IL-6 R causes temporary reduction inLMP1tg mice have significantly enlarged LNs and SP,
anti-dsDNA Abs and nephritis (Kiberd, 1993). A subsetelevated serum IL-6, high levels of GC B cells, and an
of autoantibodies produced in mice is IL-6 dependentenhanced propensity for autoimmunity. Thus, expres-
(Ishihara and Hirano, 2002).sion of a receptor with the LMP1 CY domain promotes
Significant increases in serum anti-dsDNA and anti-B cell hyperactivity, as well as potential abnormalities
phospholipid Abs from mCD40-LMP1tg, but not mCD40tg,in other cell types.
mice were noted in our study. Anti-DNA Abs have longMice tg for wt LMP1 expressed only in B cells develop
been correlated with autoimmune arthritic syndromeslymphoma late in life (Kulwichit et al., 1998). These mice,
(Lorenz et al., 2001) and SLE (Schiffer et al., 2002). Anti-on a CD40/ background, gave an Ag-specific re-
phospholipid Abs are directly associated with anti-sponse but failed to form GC or display affinity matura-
phospholipid syndrome (Shoenfeld, 2003) and associ-tion (Uchida et al., 1999). There are several differences
ated in many patients with RA or SLE (Marai et al., 2003).between the mice we describe here and the previous
It has been recently shown that IL-6 production by Ag-studies, due to distinct experimental goals. First, the wt
presenting cells plays a critical role in blocking the sup-LMP1tg (Kulwichit et al., 1998) is constitutively active
pressive effect of CD4CD25 T cells, allowing activa-due to its ability to self-aggregate, whereas our mCD40-
tion of Ag-specific T cells (Pasare and Medzhitov, 2003).LMP1 molecule signals when stimulated by CD154
Regulatory T cells are believed important in maintaining(Brown et al., 2001; Busch and Bishop, 2001). Secondly,
peripheral tolerance, so secretion of IL-6 by Ag-present-we used a promoter to drive expression of the trans-
ing cells could contribute to development of autoreactiv-genes not only in B cells, but in macrophages and DC
ity in mCD40LMP1 mice.
as well. We find that LMP1 is an efficient mimic of CD40
An alternative explanation for the increased autoreac-
in supporting both the GC response and affinity matura-
tivity in mCD40-LMP1tg mice could be persistence of
tion when expressed in relevant compartments and
autoreactive B cells. mCD40-LMP1tg mice have an
when engaged in a physiologically relevant context. expansion of the immature SP B cell compartment and
A prior comparison between LMP1 and CD40 signal- show evidence of spontaneous GC. Immature B cells
ing in B cells in vitro showed that LMP1 induces ampli- are normally short-lived and susceptible to negative se-
fied and/or sustained c-Jun kinase and NF-B activa- lection (Rolink et al., 2001). Perhaps mCD40-LMP1 tg-
tion, surface molecule upregulation, and Ig and IL-6 bearing B cells are less susceptible to killing because
production (Brown et al., 2001; Busch and Bishop, 2001). bystander engagement of mCD40-LMP1 by CD154
Interestingly, signaling through the LMP1 CY tail does leads to a prolonged protective effect. Alternatively,
not induce degradation of TRAFs 2 and 3, unlike CD40 unique activation pathways in mCD40-LMP1tg cells may
signaling, which results in ubiquitin- and proteasome- lead to production of factors like BAFF, which is essen-
dependent TRAF2 and 3 degradation (Brown et al., 2001, tial to viability of cells in this compartment. LMP1 has
2002). This suggests that the lack of TRAF degradation been recently shown to regulate BAFF in an NF-B de-
may contribute to prolonged signaling through LMP1. pendent manner in human B cells (He et al., 2003). Spon-
Indeed, we have preliminary evidence that stimulation taneous GCs have previously been reported in some
of mCD40-LMP1tg B cells by anti-CD40 Ab in vitro fails autoimmune mouse strains (Luzina et al., 2001); these
to stimulate degradation of TRAFs 2 and 3 (C. Moore, may arise from autoreactive B cells that escape negative
L.L.S., and G.A.B., unpublished data). Recently, we have selection due to either the release of T cell regulation or
also obtained the unexpected finding that while TRAF3 increased survival signals in the immature compartment.
negatively regulates several CD40-mediated B cell acti- While LMP1 is implicated in lymphomagenesis, we
vation pathways, LMP1 actually requires TRAF3 binding have not yet seen unequivocal evidence of lymphoma
to initiate the same pathways (Xie et al., 2004). Thus, in the relatively young mCD40-LMP1tg mice examined,
LMP1 uses multiple mechanisms to circumvent the nor- despite their lymphadenopathy and splenomegaly. This
mal regulatory controls of CD40 signaling is perhaps not surprising, as only 1/24 of the previously
While the LMP1 CY tail is an effective CD40 mimic, it studied wt LMP1tg mice developed lymphoma at ages
also has unique properties that appear to result in a 12 months, though signaling through LMP1 was con-
stitutive (Kulwichit et al., 1998). By 18 months, 42% ofreduced threshold of activation, prolongation of signals
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microinjection into fertilized mouse eggs of F2 hybrids from C57Bl/the wt LMP1tg mice did develop lymphoma, (Kulwichit
6 x SJL crosses.et al., 1998), and we intend to examine our tg mice at
Breeding of tg mice is described above in Results. Experimentsolder ages to determine whether they also show this ten-
in Figures 3–7 were performed with mice backcrossed five to eight
dency. generations, initially to normal C57Bl/6 NCR and in all subsequent
We have shown that LMP1 signals in vivo can effec- breedings to CD40/ C57Bl/6 mice. Mice were housed in a specific
pathogen-free barrier facility with restricted access, and all proce-tively substitute for CD40 signals in development of a
dures were performed as approved by the University of Iowa Animalfull TD immune response but additionally induce hyper-
Care and Use Committee.reactivity in immune cells. Interestingly, our results rein-
Offspring were routinely screened by PCR using primers specificforce the concept that LMP1 signals do not promote
for the tg (5T, 5-TGTGCTGTCTCATCATTTTGGC-3; 3T, 5T-GGA
hyperreactivity solely because wt LMP1 can self-aggre- GAAGAAGCCGACTGGG-3), for the endogenous mCD40 gene (5E,
gate. Although the hybrid molecule we tested lacks the 5-AGACCTCACACTCTGGGGGC-5 and 3 E, 5-CCACTCCTCACG
TCATCTGC-3), and for the neo-containing disrupted endogenousmembrane spanning domains that mediate this function,
mCD40KO gene (5E and 3K, 5-GCTTCCATCCGAGTACGTGC-3).signaling via the LMP1 CY domain itself by engagement
Tg-negative littermates (CD40/) and age-matched C57Bl/6 miceof the CD40 EC domain results in abnormal responses.
(NCR) were used as controls.These studies provide novel insight into how expression
of a protein produced by EBV, a virus that infects the
GC Reaction
majority of the world’s human population, may predis- Mice were immunized i.p. with 0.1 ml of 10% SRBC (Elmira Biologi-
pose toward B cell hyperreactivity that could ultimately cals, West Branch, IA) in PBS. Ten days after immunization, SPs
were harvested, soaked for 20 min in 20% sucrose in PBS, coveredcontribute to human disease, and suggest points of in-
with embedding medium (Tissue-Tek, Sakura Finetek USA Inc., Tor-tervention.
rance CA), and snap-frozen in liquid N2 and then stored at 70C.
8–10 
m sections were prepared on a Microm cryostat. Fixation,
Experimental Procedures rehydration, blocking, and staining of sections were carried out as
described (Jacob et al., 1991) with the modification that the blocking
Reagents solution contained 10% goat serum (Zymed, South San Francisco,
TNP40KLH, TNP3BSA and TNP28BSA were purchased from Biosearch CA), 100 
g/ml 2.4 G2, 2% BSA, and 0.05% Tween 20 in TBS (pH
Technology (Novato, CA). The following Abs were purchased from 7.2), and Ab staining was done in blocking solution. Staining re-
commercial sources: HM40.3 Armenian hamster IgM anti-mouse agents were anti-mouse IgM-FITC, anti-mouse CD3-PE, and PNA-
CD40 and isotype control from BD/Pharmingen, (San Diego, CA), biotin (Vector Laboratories, Burlingame, CA) followed by avidin-
Armenian hamster IgG anti-mouse CD3e-PE from eBioscience (San Alexa Fluor 350 (Molecular Probes, Eugene, OR), all at 7.7 
g/ml
Diego, CA), Gt anti-mouse IgM-FITC, AP-coupled Gt anti-IgA, -IgM, for 1 hr, with washes performed in PBS (pH 7.4). Slides were ob-
and -IgG1-specific Abs from Southern Biotechnology Associates served on a fluorescence microscope (Olympus BX60) equipped
(Birmingham, AL), and F(ab)2 anti-mouse IgG from Jackson Immu- with filters: excitation 330–385, dichroic cutoff 400 nm longpass,
noresearch (West Grove, PA). S12 mouse IgG2a anti-LMP1 was the 400–420 nm emission, used to detect Alexa Fluor 350; 470  40 nm
gift of Dr. F. Wang, Harvard University, Boston, MA. Other mono- excitation, dichroic cutoff 495 nm longpass, emission 500 nm long
clonal Abs were prepared by 50% SAS precipitation from serum- pass, to detect FITC; and 545  30 excitation, dichroic cutoff 565
free cultures. These include rat Abs: 2.4G2 IgG2a anti-FcRII, B1E3 nm longpass, emission 610 75nm to detect PE or Cy3. The micro-
IgG1 anti- mouse IgE, EM95 IgG2a anti-mouse IgE, 32C11 IgG2a scope was fitted with a Sensys camera (Photometrics, Tucson, AZ).
anti-mouse IL-6, 20F11 IgG1 anti-mouse IL-6, 1C10 IgG2a anti-CD40, Images were analyzed by using ImagePro 4.5 software (Media Cy-
RA3-6B2 IgG2a anti-B220, 7E9 IgG anti-CD21/CD35, B7-6 IgG anti- bernetics, Silver Spring, MD).
mouse IgM, and B3B4 IgG2a anti-CD23; mouse Abs HO13.4 IgM
anti-thy1.2, BP-1 IgG2a anti-Ly-51, and Mac1 IgG1 anti-CD11b; and Ab Response to T-D Ag
N418 Armenian hamster IgG anti-CD11c. Antibodies used in flow Mice were immunized IP with 100 
g TNP40KLH in alum on d0 and
cytometry were FITC, Cy5, or biotin labeled according to established boosted on day 21. Mice were bled by retroorbital puncture under
protocols. Fluorochrome- or biotin-conjugated isotype controls CO2 anesthesia on days 0, 7, 14, and 28. Sera were frozen at 20C.
(eBioscience, BD Biosciences) were used as negative controls in
all experiments. Flow Cytometry
Streptavidin-PE, -FITC, or -Cy5 was purchased from eBioscience. Cells from the SP, BM, peritoneum, and LNs of the mCD40-LMP1tg
Sf9 insect cells infected with either wild-type or recombinant bacu- and mCD40tg mice were studied as described (Waldschmidt et al.,
lovirus containing the cDNA encoding murine CD154 were pre- 2002). Listmode data were acquired on a FACSVantage (Becton
viously described (Bishop et al., 1995). PCR primers were synthe- Dickinson, Mountain View, CA) by using Cell Quest software. The
sized by Integrated DNA Technologies (IDT) (Coralville, IA). results were analyzed by using FlowJo software (TreeStar, San Car-
los, CA).
Generation and Testing of tg Mice
T Depleted SP CellsmCD40 was cloned by RT-PCR from the B cell line M12.4.1. The
T depleted SP cells used in the IL-6 experiments were prepared bymCD40 primer 5-AAGTCGACGCCATGGTGTCTTTGCCTCGG-3,
treatment with anti-thy1.2 (HO13.4) mAb and C (Pel-Freez, Browndesigned to give mCD40 a consensus Kozak sequence (Kozak,
Deer, WI).1986) was used with the 3mCD40 primer 5-CAGGATCCGGCTCAT
CTCAAACTTCA-3. The PCR product was cloned into pRSV.5 (neo)
(Long et al., 1991). This plasmid, pmCD40b, and phCD40LMP1 IL-6 Studies
For in vitro studies, T depleted SP cells (	90% B220) were cultured(Brown et al., 2001) were used as templates in PCR SOEing (Horton,
1995) by using primers 5mCD40 with 3LMP1: 5-AATCTAGAAAGC in 75,000 cells/200
l triplicate cultures in the presence of the follow-
ing for 72 hr: medium alone, HM40.3 anti-CD40 or isotype controlCTATGACATGGTAATGCC-3 and the SOEing primer 5-CATCAC
TGTGTCGTTGTCCATGGATATAGAGAAACACCCCGAAAATG-3 to Ab at 2 
g/ml, or CD154-bearing or control SF9 insect cells at 1
SF9 cell/5 mouse cells. Supernatants were assayed by quantitativegenerate pmCD40-LMP1 in pRSV.5 (neo). The MHC class II E pro-
moter from pDOI-5 (Kouskoff et al., 1993) (a gift from Dr. D. Mathis, mouse IL-6 ELISA, as described (Baccam and Bishop, 1999). In
some experiments the SP cells were further purified by binding toHarvard University) drove expression of the transgenes in pBlDOI
(Figure 1A). Two exons from rabbit -globin were included to im- anti-CD43 magnetic beads (Miltenyi Biotec, Auburn, CA). For serum
IL-6, a commercial kit was used (R & D Systems, Minneapolis, MN).prove efficiency of tg mRNA processing but are not expressed as
part of the tg protein. Tg were excised with SacII and ClaI before Intracellular IL-6 was detected in cells cultured for 48 hr with 2
g/ml
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anti-CD40 or isotype control, with the addition of 1 
g/ml Brefeldin A visualized with a chemiluminescent detection system (SuperSignal
West Pico, Pierce, Rockford, IL).(Golgistop, BD Biosciences) for the last 4 hr of culture. Cells were
stained with Abs to surface Ags as described above, fixed, and
permeabilized and then stained with anti-mouse IL-6 or an isotype Statistical Analyses
control Ab. Analyses were performed with GraphPad Instat software (San Diego,
CA). For comparisons of specific Abs, organ weights, B and T cell
subset percentage and affinity maturation, a one-way analysis ofIsotype and Ag-Specific Ig ELISA
variance was used with the Dunnett multiple comparisons posttest.The assay for isotype-specific anti-TNP Abs was performed by using
For analysis of autoantibody data, the Fisher’s exact test was usedELISA (Waldschmidt et al., 2002). Plates were read on a Versamax
to compare mCD40-LMP1 data to other groups.plate reader (Molecular Devices, Sunnyvale, CA) and results ana-
lyzed by using SoftMax Pro 4.0 software. Standard curves were
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